Skip to main content
NewslettersWatchlist

Quest Diagnostics Inc(DGX-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low155.43
Day High157.01
Open:155.83
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
Barchart
Stocks Recover and Settle Mixed on Strong Earnings Results
Barchart
Stocks Under Pressure on Reduced Fed Rate Cut Expectations
Barchart
Stocks Fall as Bond Yields Rise on Expectations of Slower Fed Rate Cuts
Stock Target Advisor
Quest Diagnostics’ Q3 2024 Earnings: EPS and Revenue Beat Expectations
Newswire.ca
Quest Diagnostics Completes Acquisition of LifeLabs, Enhancing Access to Diagnostic Innovation
Barchart
S&P 500 and Nasdaq 100 Post Record Highs on Fed Rate Cut Hopes
Barchart
Stocks Supported as Weak US Economic News Bolsters Hopes for Fed Rate Cuts
Barchart
Stocks Climb as Nasdaq 100 Posts a New Record High on Falling Bond Yields
SYNDTGAM
Quest Diagnostics expands into Canada with $1.35-billion LifeLabs deal
Newswire.ca
Quest Diagnostics to Acquire LifeLabs from OMERS, Enhancing Diagnostic Services for Canadians
The Globe and Mail
U.S. medical testing giant Quest Diagnostics close to acquiring LifeLabs, sources say
Motley Fool
Firing on All Cylinders Indeed
PR Newswire
Multiple Myeloma Therapeutics Market Expected to Reach $4.26 Billion in 2030
PR Newswire
Neway Forms Lab Services Agreement with Quest Diagnostics to Speed Quality ESRD Testing
PR Newswire
Quest Diagnostics to Release Third Quarter 2023 Financial Results on October 24, 2023
PR Newswire
Quest Diagnostics to Speak at the Baird 2023 Global Healthcare Conference
PR Newswire
Quest Diagnostics Releases 2022 Corporate Responsibility Report
PR Newswire
Quest Diagnostics Granted FDA Breakthrough Designation for its Adeno-associated virus (AAV) Test
ACCESSWIRE
Making Connections To Care: Quest Supports Inspiring Health Equity Event Hosted by Sisters on the Vineyard
Motley Fool
Why Bionano Genomics Stock Tanked Today
PR Newswire
Quest Diagnostics Declares Quarterly Cash Dividend
Motley Fool
More Alzheimer's Treatments Are Coming: This Company Can Help With Early Detection

Profile

Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services and Diagnostic Solutions. The company's focus is on two elements - to accelerate growth and to drive operational excellence. Restore Growth: The company has adopted seven tactical approaches to accelerate growth such as sales and marketing; development of esoteric testing through a disease focus; partnerships with hospitals and successful testing of international IDNs; creation of value from information assets; leadership in companion diagnostics; extension into adjacent markets. Drive Operational excellence: The company plans to focus on four strategic requirements - to enhance end-to-end customer value chain, enterprise information technology architecture, business performance tools and cost excellence.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2024 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.